1. Home
  2. BSL vs SWKH Comparison

BSL vs SWKH Comparison

Compare BSL & SWKH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Blackstone

BSL

Blackstone

HOLD

Current Price

$13.07

Market Cap

176.1M

Sector

Finance

ML Signal

HOLD

Logo SWK Holdings Corporation

SWKH

SWK Holdings Corporation

N/A

Current Price

$16.65

Market Cap

205.9M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
BSL
SWKH
Founded
2010
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Diversified Financial Services
Sector
Finance
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
176.1M
205.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
BSL
SWKH
Price
$13.07
$16.65
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$18.00
AVG Volume (30 Days)
47.6K
5.6K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
9.55%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$52.93
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$9.18
Revenue Growth
N/A
N/A
52 Week Low
$13.12
$13.00
52 Week High
$14.35
$18.66

Technical Indicators

Market Signals
Indicator
BSL
SWKH
Relative Strength Index (RSI) 22.05 31.64
Support Level N/A $16.15
Resistance Level $13.70 $17.08
Average True Range (ATR) 0.06 0.24
MACD -0.01 -0.08
Stochastic Oscillator 0.00 9.38

Price Performance

Historical Comparison
BSL
SWKH

About BSL Blackstone

Blackstone Senior Floating Rate Term Fund is a diversified, closed-end management investment company. Its primary investment objective is to seek high current income, with a secondary objective to seek preservation of capital, consistent with its primary goal of high current income. It also invests in second-lien loans and high yield bonds and employs financial leverage which may increase the risk to the Fund.

About SWKH SWK Holdings Corporation

SWK Holdings Corp is a healthcare capital provider. The company offers financing solutions to various life science companies, institutions, and inventors. It involves monetizing cash flow streams derived from commercial-stage products and related intellectual property through royalty purchases and financings, as well as through the creation of synthetic revenue interests in commercialized products. Through its wholly-owned subsidiary, it also provides non-discretionary investment advisory services to institutional clients. The company's operating segments are Finance Receivables and Pharmaceutical Development Services. It generates maximum revenue from the Finance Receivables segment.

Share on Social Networks: